<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00989209</url>
  </required_header>
  <id_info>
    <org_study_id>CAPPesq 890/04</org_study_id>
    <nct_id>NCT00989209</nct_id>
  </id_info>
  <brief_title>Myofunctional Therapy in Facial Palsy</brief_title>
  <official_title>Improvement of Facial Symmetry With Myofunctional Therapy Combined to Botulinum Toxin Injections in Long Standing Facial Paralysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: Quantify the benefits of myofunctional therapy associated to botulinum toxin
      injection in patients with long standing facial unilateral palsy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty-five patients with long standing facial palsy were studied; all had been previously
      treated for facial reanimation. Patients were randomly divided in two groups; Group A did the
      myofunctional therapy sessions with the speech therapist before the botulinum toxin
      injection, while the participants of Group B did the myofunctional therapy after it.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical score</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Facial Disability Index (self-report instrument)</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Facial Paralysis</condition>
  <arm_group>
    <arm_group_label>A: myofunctional prior to botulinum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All the facial paralysis patients received treatment with botulinum toxin type A to the non-paralyzed side, according to the Institution Protocol. To the participants of Group A, botulinum toxin was applied after myofunctional therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B: myofunctional after botulinum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All the facial paralysis patients received treatment with botulinum toxin type A to the non-paralyzed side, according to the Institution Protocol. To the participants of Group B, botulinum toxin was applied before myofunctional therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum Toxin Type A</intervention_name>
    <description>All the patients received a one-time treatment with botulinum toxin type A to the non-paralyzed side, according to the Institution Protocol,the total dose used per patient ranged from 15-69U, mean 37.9Â±5.4U.</description>
    <arm_group_label>A: myofunctional prior to botulinum</arm_group_label>
    <arm_group_label>B: myofunctional after botulinum</arm_group_label>
    <other_name>BOTOX (Allergan)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>myofunctional therapy</intervention_name>
    <description>All the patients were submitted to individual myofunctional therapy with the speech therapist, once a week, by four weeks.The myofunctional therapy began with isometric maneuvers for muscular elongation on the non paralyzed side, and on the paralyzed side when microsurgical reconstruction was present. It also included isotonic maneuvers to increase muscle tonus and isokinetic maneuvers to increase force on the paralyzed side.</description>
    <arm_group_label>A: myofunctional prior to botulinum</arm_group_label>
    <arm_group_label>B: myofunctional after botulinum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  facial paralysis with more than 2 years elapsed since the onset of symptoms

          -  surgically treated for reanimation at least 12 months before

          -  static and/or dynamic facial asymmetry causing aesthetic concern

        Exclusion Criteria:

          -  spastic paralysis

          -  serious systemic or neuromuscular diseases

          -  cognition impairment

          -  pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>62 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandra G Salles</last_name>
    <role>Study Director</role>
    <affiliation>University of Sao Paulo General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcus C Ferreira</last_name>
    <role>Study Chair</role>
    <affiliation>University of Sao Paulo General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paula N Toledo</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudia F Andrade</last_name>
    <role>Study Director</role>
    <affiliation>University of Sao Paulo General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Sao Paulo General Hospital</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Salles AG, Toledo PN, Ferreira MC. Botulinum toxin injection in long-standing facial paralysis patients: improvement of facial symmetry observed up to 6 months. Aesthetic Plast Surg. 2009 Jul;33(4):582-90. doi: 10.1007/s00266-009-9337-9. Epub 2009 Mar 28.</citation>
    <PMID>19330369</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2009</study_first_submitted>
  <study_first_submitted_qc>October 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2009</study_first_posted>
  <last_update_submitted>October 2, 2009</last_update_submitted>
  <last_update_submitted_qc>October 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>Paula Nunes Toledo</name_title>
    <organization>University of Sao Paulo General Hospital</organization>
  </responsible_party>
  <keyword>facial paralysis</keyword>
  <keyword>asymmetry</keyword>
  <keyword>myofunctional therapy</keyword>
  <keyword>botulinum toxin</keyword>
  <keyword>facial evaluation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facies</mesh_term>
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Facial Paralysis</mesh_term>
    <mesh_term>Bell Palsy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

